FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 342:1027-1038 April 6, 2000 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

In 1872, Moritz Kaposi, a Hungarian dermatologist, described five men with aggressive "idiopathic multiple pigmented sarcomas of the skin."¹ One patient died of gastrointestinal bleeding 15 months after the initial appearance of the skin lesions, and an autopsy showed visceral lesions in the lungs and the gastrointestinal tract. Subsequently, other investigators described four clinical variants of Kaposi's sarcoma that had identical histologic features but developed in specific populations and had different sites of involvement and rates of progression (Table 1). In the light of recent discoveries regarding the viral pathogenesis of Kaposi's sarcoma, these variants most likely represent . . . [Full Text of this Article]

Clinical Variants of Kaposi's Sarcoma

Classic Kaposi's Sarcoma

Endemic Kaposi's Sarcoma

Immunosuppression-Associated, or Transplantation-Associated, Kaposi's Sarcoma

Epidemic, or AIDS-Associated, Kaposi's Sarcoma

Kaposi's Sarcoma–Associated Herpesvirus

Epidemiology of Kaposi's Sarcoma and KSHV

KSHV Infection in Humans

Rates of Infection in Various Populations

Transmission

Natural History of KSHV Infection

Treatment

Classic Kaposi's Sarcoma

            Radiation Therapy

            Systemic or Combination Therapy

Endemic Kaposi's Sarcoma

Immunosuppression-Associated Kaposi's Sarcoma

Epidemic Kaposi's Sarcoma

            Radiation Therapy

            Cytotoxic Drugs

            Biologic Agents

            Interferon in Combination with Antiretroviral Therapy

            Experimental Therapies

Prevention

Source Information

From the Departments of Medicine (K.A.) and Pathology (Y.C.), Columbia University College of Physicians and Surgeons, New York.

Address reprint requests to Dr. Chang at P&S14-442, Department of Pathology, Columbia University College of Physicians and Surgeons, 630 W. 168th St., New York, NY 10032.

References

Related Letters:

Kaposi's Sarcoma
Washenik K., Clark-Loeser L., Friedman-Kien A., Simonart T., Vooren J.-P. V., Meuris S., Mazzone A., Ottini E., Paulli M., Antman K., Chang Y.
Extract | Full Text  
N Engl J Med 2000; 343:581-584, Aug 24, 2000. Correspondence

This article has been cited by other articles:

• Raghu, H., Sharma-Walia, N., Veettil, M. V., Sadagopan, S., Chandran, B. (2009). Kaposi's Sarcoma-Associated Herpesvirus Utilizes an Actin Polymerization-Dependent Macropinocytic Pathway To Enter Human Dermal Microvascular Endothelial and Human Umbilical Vein Endothelial Cells. J. Virol. 83: 4895-4911 [Abstract] [Full Text]  
• Morris, V. A., Punjabi, A. S., Lagunoff, M. (2008). Activation of Akt through gp130 Receptor Signaling Is Required for Kaposi's Sarcoma-Associated Herpesvirus-Induced Lymphatic Reprogramming of Endothelial Cells. J. Virol. 82: 8771-8779 [Abstract] [Full Text]  
• (2008). Cutaneous Tumors, Massive Lymphadenopathy, and Secondary Lymphedema in a 16-Year-Old Boy--Diagnosis. Arch Dermatol 144: 1217-1222 [Full Text]  
• Subramanian, R., D'Auvergne, O., Kong, H., Kousoulas, K. G. (2008). The Cytoplasmic Terminus of Kaposi's Sarcoma-Associated Herpesvirus Glycoprotein B Is Not Essential for Virion Egress and Infectivity. J. Virol. 82: 7144-7154 [Abstract] [Full Text]  
• Wang, Y., Li, H., Tang, Q., Maul, G. G., Yuan, Y. (2008). Kaposi's Sarcoma-Associated Herpesvirus ori-Lyt-Dependent DNA Replication: Involvement of Host Cellular Factors. J. Virol. 82: 2867-2882 [Abstract] [Full Text]  
• Garrigues, H. J., Rubinchikova, Y. E., DiPersio, C. M., Rose, T. M. (2008). Integrin {alpha}V 3 Binds to the RGD Motif of Glycoprotein B of Kaposi's Sarcoma-Associated Herpesvirus and Functions as an RGD-Dependent Entry Receptor. J. Virol. 82: 1570-1580 [Abstract] [Full Text]  
• Makombe, S. D, Harries, A. D, Kwong-Leung Yu, J., Hochgesang, M., Mhango, E., Weigel, R., Pasulani, O., Fitzgerald, M., Schouten, E. J, Libamba, E. (2008). Outcomes of patients with Kaposi's sarcoma who start antiretroviral therapy under routine programme conditions in Malawi. Trop Doct 38: 5-7 [Abstract] [Full Text]  
• Burns, J., Shaknovich, R., Lau, J., Haramati, L. B. (2007). Oncogenic Viruses in AIDS: Mechanisms of Disease and Intrathoracic Manifestations. Am. J. Roentgenol. 189: 1082-1087 [Abstract] [Full Text]  
• Nun, T. K., Kroll, D. J., Oberlies, N. H., Soejarto, D. D., Case, R. J., Piskaut, P., Matainaho, T., Hilscher, C., Wang, L., Dittmer, D. P., Gao, S.-J., Damania, B. (2007). Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma associated herpesvirus. Molecular Cancer Therapeutics 6: 2360-2370 [Abstract] [Full Text]  
• Bihl, F., Narayan, M., Chisholm, J. V. III, Henry, L. M., Suscovich, T. J., Brown, E. E., Welzel, T. M., Kaufmann, D. E., Zaman, T. M., Dollard, S., Martin, J. N., Wang, F., Scadden, D. T., Kaye, K. M., Brander, C. (2007). Lytic and Latent Antigens of the Human Gammaherpesviruses Kaposi's Sarcoma-Associated Herpesvirus and Epstein-Barr Virus Induce T-Cell Responses with Similar Functional Properties and Memory Phenotypes. J. Virol. 81: 4904-4908 [Abstract] [Full Text]  
• Fuse, S., Bellfy, S., Yagita, H., Usherwood, E. J. (2007). CD8+ T Cell Dysfunction and Increase in Murine Gammaherpesvirus Latent Viral Burden in the Absence of 4-1BB Ligand. J. Immunol. 178: 5227-5236 [Abstract] [Full Text]  
• MOHANNA, S., MACO, V., GOWN, A., MORALES, D., BRAVO, F., GOTUZZO, E. (2006). Is classic kaposi's sarcoma endemic in peru?: report of a case in an indigenous patient.. Am J Trop Med Hyg 75: 324-326 [Abstract] [Full Text]  
• Wu, W., Vieira, J., Fiore, N., Banerjee, P., Sieburg, M., Rochford, R., Harrington, W. Jr, Feuer, G. (2006). KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo. Blood 108: 141-151 [Abstract] [Full Text]  
• Little, R. F., Pluda, J. M., Wyvill, K. M., Rodriguez-Chavez, I. R., Tosato, G., Catanzaro, A. T., Steinberg, S. M., Yarchoan, R. (2006). Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma. Blood 107: 4650-4657 [Abstract] [Full Text]  
• de Graaff, A. E., Weening, J. J., Krediet, R. T. (2005). Massive oedema in a Cape Verde sailor. Nephrol Dial Transplant 20: 2545-2547 [Full Text]  
• Stratigos, A. J., Malanos, D., Touloumi, G., Antoniou, A., Potouridou, I., Polydorou, D., Katsambas, A. D., Whitby, D., Mueller, N., Stratigos, J. D., Hatzakis, A. (2005). Association of Clinical Progression in Classic Kaposi's Sarcoma With Reduction of Peripheral B Lymphocytes and Partial Increase in Serum Immune Activation Markers. Arch Dermatol 141: 1421-1426 [Abstract] [Full Text]  
• Caselli, E., Galvan, M., Cassai, E., Caruso, A., Sighinolfi, L., Di Luca, D. (2005). Human herpesvirus 8 enhances human immunodeficiency virus replication in acutely infected cells and induces reactivation in latently infected cells. Blood 106: 2790-2797 [Abstract] [Full Text]  
• (2005). Purple Polypoid Masses on the Legs--Diagnosis. Arch Dermatol 141: 1311-1316 [Full Text]  
• Fuji, R. N., Patton, K. M., Steinbach, T. J., Schulman, F. Y., Bradley, G. A., Brown, T. T., Wilson, E. A., Summers, B. A. (2005). Feline Systemic Reactive Angioendotheliomatosis: Eight Cases and Literature Review. Vet Pathol 42: 608-617 [Abstract] [Full Text]  
• Sharma-Walia, N., Krishnan, H. H., Naranatt, P. P., Zeng, L., Smith, M. S., Chandran, B. (2005). ERK1/2 and MEK1/2 Induced by Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Early during Infection of Target Cells Are Essential for Expression of Viral Genes and for Establishment of Infection. J. Virol. 79: 10308-10329 [Abstract] [Full Text]  
• Zhang, X., Wang, J. F., Chandran, B., Persaud, K., Pytowski, B., Fingeroth, J., Groopman, J. E. (2005). Kaposi's Sarcoma-associated Herpesvirus Activation of Vascular Endothelial Growth Factor Receptor 3 Alters Endothelial Function and Enhances Infection. J. Biol. Chem. 280: 26216-26224 [Abstract] [Full Text]  
• Gentile, G., Capobianchi, A., Volpi, A., Palu, G., Pica, F., Calistri, A., Biasolo, M. A., Martino, P. (2005). Human Herpesvirus 8 DNA in Serum During Seroconversion in Allogeneic Bone Marrow Transplant Recipients. JNCI J Natl Cancer Inst 97: 1008-1011 [Abstract] [Full Text]  
• Sugaya, M., Watanabe, T., Yang, A., Starost, M. F., Kobayashi, H., Atkins, A. M., Borris, D. L., Hanan, E. A., Schimel, D., Bryant, M. A., Roberts, N., Skobe, M., Staskus, K. A., Kaldis, P., Blauvelt, A. (2005). Lymphatic dysfunction in transgenic mice expressing KSHV k-cyclin under the control of the VEGFR-3 promoter. Blood 105: 2356-2363 [Abstract] [Full Text]  
• Moosa, M.R. (2005). Kaposi's sarcoma in kidney transplant recipients: a 23-year experience. QJM 98: 205-214 [Abstract] [Full Text]  
• (2005). Multiple Violaceous Papules at an Amputation Site--Diagnosis. Arch Dermatol 141: 263-268 [Full Text]  
• Naranatt, P. P., Krishnan, H. H., Smith, M. S., Chandran, B. (2005). Kaposi's Sarcoma-Associated Herpesvirus Modulates Microtubule Dynamics via RhoA-GTP-Diaphanous 2 Signaling and Utilizes the Dynein Motors To Deliver Its DNA to the Nucleus. J. Virol. 79: 1191-1206 [Abstract] [Full Text]  
• Coras, B., Hafner, C., Reichle, A., Hohenleutner, U., Szeimies, R.-M., Landthaler, M., Vogt, T. (2004). Antiangiogenic Therapy With Pioglitazone, Rofecoxib, and Trofosfamide in a Patient With Endemic Kaposi Sarcoma. Arch Dermatol 140: 1504-1507 [Abstract] [Full Text]  
• Martro, E., Cannon, M. J., Dollard, S. C., Spira, T. J., Laney, A. S., Ou, C.-Y., Pellett, P. E. (2004). Evidence for both Lytic Replication and Tightly Regulated Human Herpesvirus 8 Latency in Circulating Mononuclear Cells, with Virus Loads Frequently below Common Thresholds of Detection. J. Virol. 78: 11707-11714 [Abstract] [Full Text]  
• Deutsch, E., Cohen, A., Kazimirsky, G., Dovrat, S., Rubinfeld, H., Brodie, C., Sarid, R. (2004). Role of Protein Kinase C {delta} in Reactivation of Kaposi's Sarcoma-Associated Herpesvirus. J. Virol. 78: 10187-10192 [Abstract] [Full Text]  
• Staudt, M. R., Kanan, Y., Jeong, J. H., Papin, J. F., Hines-Boykin, R., Dittmer, D. P. (2004). The Tumor Microenvironment Controls Primary Effusion Lymphoma Growth in Vivo. Cancer Res. 64: 4790-4799 [Abstract] [Full Text]  
• Luna, R. E., Zhou, F., Baghian, A., Chouljenko, V., Forghani, B., Gao, S.-J., Kousoulas, K. G. (2004). Kaposi's Sarcoma-Associated Herpesvirus Glycoprotein K8.1 Is Dispensable for Virus Entry. J. Virol. 78: 6389-6398 [Abstract] [Full Text]  
• Sergerie, Y., Abed, Y., Roy, J., Boivin, G. (2004). Comparative Evaluation of Three Serological Methods for Detection of Human Herpesvirus 8-Specific Antibodies in Canadian Allogeneic Stem Cell Transplant Recipients. J. Clin. Microbiol. 42: 2663-2667 [Abstract] [Full Text]  
• Cooray, S. (2004). The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival. J. Gen. Virol. 85: 1065-1076 [Abstract] [Full Text]  
• Sharma-Walia, N., Naranatt, P. P., Krishnan, H. H., Zeng, L., Chandran, B. (2004). Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 Envelope Glycoprotein gB Induces the Integrin-Dependent Focal Adhesion Kinase-Src-Phosphatidylinositol 3-Kinase-Rho GTPase Signal Pathways and Cytoskeletal Rearrangements. J. Virol. 78: 4207-4223 [Abstract] [Full Text]  
• SODHI, A., MONTANER, S., GUTKIND, J. S. (2004). Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis?. FASEB J. 18: 422-427 [Abstract] [Full Text]  
• Naranatt, P. P., Krishnan, H. H., Svojanovsky, S. R., Bloomer, C., Mathur, S., Chandran, B. (2004). Host Gene Induction and Transcriptional Reprogramming in Kaposi's Sarcoma-Associated Herpesvirus (KSHV/HHV-8)-Infected Endothelial, Fibroblast, and B Cells: Insights into Modulation Events Early during Infection. Cancer Res. 64: 72-84 [Abstract] [Full Text]  
• Cool, C. D., Rai, P. R., Yeager, M. E., Hernandez-Saavedra, D., Serls, A. E., Bull, T. M., Geraci, M. W., Brown, K. K., Routes, J. M., Tuder, R. M., Voelkel, N. F. (2003). Expression of Human Herpesvirus 8 in Primary Pulmonary Hypertension. NEJM 349: 1113-1122 [Abstract] [Full Text]  
• Rosano, L., Spinella, F., Di Castro, V., Nicotra, M. R., Albini, A., Natali, P. G., Bagnato, A. (2003). Endothelin Receptor Blockade Inhibits Molecular Effectors of Kaposi's Sarcoma Cell Invasion and Tumor Growth in Vivo. Am. J. Pathol. 163: 753-762 [Abstract] [Full Text]  
• Akula, S. M., Naranatt, P. P., Walia, N.-S., Wang, F.-Z., Fegley, B., Chandran, B. (2003). Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Infection of Human Fibroblast Cells Occurs through Endocytosis. J. Virol. 77: 7978-7990 [Abstract] [Full Text]  
• Whitby, D., Stossel, A., Gamache, C., Papin, J., Bosch, M., Smith, A., Kedes, D. H., White, G., Kennedy, R., Dittmer, D. P. (2003). Novel Kaposi's Sarcoma-Associated Herpesvirus Homolog in Baboons. J. Virol. 77: 8159-8165 [Abstract] [Full Text]  
• Lundquist, A., Barre, B., Bienvenu, F., Hermann, J., Avril, S., Coqueret, O. (2003). Kaposi sarcoma-associated viral cyclin K overrides cell growth inhibition mediated by oncostatin M through STAT3 inhibition. Blood 101: 4070-4077 [Abstract] [Full Text]  
• Dittmer, D. P. (2003). Transcription Profile of Kaposi's Sarcoma-associated Herpesvirus in Primary Kaposi's Sarcoma Lesions as Determined by Real-Time PCR Arrays. Cancer Res. 63: 2010-2015 [Abstract] [Full Text]  
• Spiller, O. B., Blackbourn, D. J., Mark, L., Proctor, D. G., Blom, A. M. (2003). Functional Activity of the Complement Regulator Encoded by Kaposi's Sarcoma-associated Herpesvirus. J. Biol. Chem. 278: 9283-9289 [Abstract] [Full Text]  
• Wang, F.-Z., Akula, S. M., Sharma-Walia, N., Zeng, L., Chandran, B. (2003). Human Herpesvirus 8 Envelope Glycoprotein B Mediates Cell Adhesion via Its RGD Sequence. J. Virol. 77: 3131-3147 [Abstract] [Full Text]  
• Naranatt, P. P., Akula, S. M., Zien, C. A., Krishnan, H. H., Chandran, B. (2002). Kaposi's Sarcoma-Associated Herpesvirus Induces the Phosphatidylinositol 3-Kinase-PKC-{zeta}-MEK-ERK Signaling Pathway in Target Cells Early during Infection: Implications for Infectivity. J. Virol. 77: 1524-1539 [Abstract] [Full Text]  
• Bowser, B. S., DeWire, S. M., Damania, B. (2002). Transcriptional Regulation of the K1 Gene Product of Kaposi's Sarcoma-Associated Herpesvirus. J. Virol. 76: 12574-12583 [Abstract] [Full Text]  
• Grossman, Z., Iscovich, J., Schwartz, F., Azizi, E., Klepfish, A., Schattner, A., Sarid, R. (2002). Absence of Kaposi Sarcoma Among Ethiopian Immigrants to Israel Despite High Seroprevalence of Human Herpesvirus 8. Mayo Clin Proc. 77: 905-909 [Abstract]  
• Sarid, R., Klepfish, A., Schattner, A. (2002). Virology, Pathogenetic Mechanisms, and Associated Diseases of Kaposi Sarcoma-Associated Herpesvirus (Human Herpesvirus 8). Mayo Clin Proc. 77: 941-949 [Abstract]  
• Ablashi, D. V., Chatlynne, L. G., Whitman, J. E. Jr., Cesarman, E. (2002). Spectrum of Kaposi's Sarcoma-Associated Herpesvirus, or Human Herpesvirus 8, Diseases. Clin. Microbiol. Rev. 15: 439-464 [Abstract] [Full Text]  
• Emond, J.-P., Marcelin, A.-G., Dorent, R., Milliancourt, C., Dupin, N., Frances, C., Agut, H., Gandjbakhch, I., Calvez, V. (2002). Kaposi's Sarcoma Associated with Previous Human Herpesvirus 8 Infection in Heart Transplant Recipients. J. Clin. Microbiol. 40: 2217-2219 [Abstract] [Full Text]  
• Fakhari, F. D., Dittmer, D. P. (2002). Charting Latency Transcripts in Kaposi's Sarcoma-Associated Herpesvirus by Whole-Genome Real-Time Quantitative PCR. J. Virol. 76: 6213-6223 [Abstract] [Full Text]  
• Fata, F., Mirza, A., Bernath, A. (2002). Skin Lesions in Melanoma and Kaposi's Sarcoma: Case 3. Familial Classic Mediterranean Kaposi's Sarcoma. JCO 20: 1415-1418 [Full Text]  
• Schecter, W. P. (2001). Human Immunodeficiency Virus and Malignancy: Thoughts on Viral Oncogenesis. Arch Surg 136: 1419-1425 [Full Text]  
• Davis, D. A., Rinderknecht, A. S., Zoeteweij, J. P., Aoki, Y., Read-Connole, E. L., Tosato, G., Blauvelt, A., Yarchoan, R. (2001). Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus. Blood 97: 3244-3250 [Abstract] [Full Text]  
• Moore, P. S. (2000). The Emergence of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8). NEJM 343: 1411-1413 [Full Text]  
• Foster, C. B., Lehrnbecher, T., Samuels, S., Stein, S., Mol, F., Metcalf, J. A., Wyvill, K., Steinberg, S. M., Kovacs, J., Blauvelt, A., Yarchoan, R., Chanock, S. J. (2000). An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. Blood 96: 2562-2567 [Abstract] [Full Text]  
• Washenik, K., Clark-Loeser, L., Friedman-Kien, A., Simonart, T., Vooren, J.-P. V., Meuris, S., Mazzone, A., Ottini, E., Paulli, M., Antman, K., Chang, Y. (2000). Kaposi's Sarcoma. NEJM 343: 581-584 [Full Text]